Login / Signup

Effects of the Omicron variant of coronavirus disease 2019 on anaemia treatment for patients undergoing peritoneal dialysis.

Qinghua YangXiaowan FangXiaoying RenYujing PanMei WangJiaxiang Ding
Published in: Nephrology (Carlton, Vic.) (2024)
Roxadustat was effective than rhEPO for treating anaemia in patients undergoing PD who were infected with the Omicron variant of COVID-19.
Keyphrases
  • coronavirus disease
  • patients undergoing
  • peritoneal dialysis
  • end stage renal disease
  • respiratory syndrome coronavirus
  • sars cov
  • chronic kidney disease
  • iron deficiency